The global market for Sacroiliac Joint Fusion Injections and RF Ablation was estimated at US$498.4 Million in 2024 and is projected to reach US$1.5 Billion by 2030, growing at a CAGR of 20.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Sacroiliac Joint Fusion Injections and RF Ablation market.
Segments: Indication (Degenerative Sacroilitis, Sacral Disruption, Trauma); Type (Diagnosis, Treatment); End-Use (Hospitals, Ambulatory Surgery Centers, Others)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
Global Sacroiliac Joint Fusion Market - Key Trends & Drivers Summarized
Why Is Sacroiliac Joint Fusion Gaining Prominence In Orthopedic Treatments?
Sacroiliac (SI) joint dysfunction is a significant cause of lower back pain, affecting millions of people worldwide. As awareness of SI joint-related pain grows, sacroiliac joint fusion is becoming a widely adopted treatment option for patients who do not respond to conservative therapies such as physical therapy, pain management, and injections. The procedure involves stabilizing the SI joint using implants or bone grafts to reduce pain and improve mobility. The increasing prevalence of degenerative joint diseases, trauma-related injuries, and lifestyle factors such as obesity and prolonged sitting are fueling demand for SI joint fusion surgeries. Additionally, advancements in minimally invasive surgical techniques are making the procedure safer, reducing recovery times, and improving patient outcomes. With an aging global population and rising healthcare expenditure, the sacroiliac joint fusion market is experiencing strong growth.What Technological Innovations Are Transforming Sacroiliac Joint Fusion Procedures?
Advancements in medical technology are significantly enhancing the precision and effectiveness of SI joint fusion procedures. The development of minimally invasive surgical (MIS) techniques has reduced operative times, post-surgical pain, and recovery periods. Image-guided navigation systems and robotic-assisted surgery are improving surgical accuracy, reducing the risk of complications. Additionally, biocompatible implants made from titanium and 3D-printed porous materials are increasing the success rates of fusion procedures by promoting bone growth and stability. The use of biologics, such as bone graft substitutes and growth factors, is also enhancing fusion outcomes. These innovations are making sacroiliac joint fusion a more attractive option for both patients and healthcare providers.Which Patient Groups And Healthcare Sectors Are Driving The Demand For SI Joint Fusion?
The primary patient groups benefiting from sacroiliac joint fusion include individuals suffering from chronic lower back pain, arthritis, trauma-related injuries, and post-pregnancy pelvic instability. Geriatric patients, who are more prone to degenerative joint conditions, represent a significant portion of the market. Additionally, athletes and individuals engaged in physically demanding jobs are at higher risk of SI joint dysfunction, increasing demand for surgical interventions. The hospital and ambulatory surgery center (ASC) sectors are experiencing heightened adoption of SI joint fusion procedures due to improved reimbursement policies and cost-effective outpatient surgical options. As more orthopedic specialists and pain management clinics incorporate SI joint fusion into their treatment offerings, the market is expected to expand further.What Factors Are Fueling The Growth Of The Sacroiliac Joint Fusion Market?
The growth in the sacroiliac joint fusion market is driven by increasing awareness of SI joint dysfunction, advancements in minimally invasive surgery, and a rising aging population prone to degenerative joint diseases. The growing adoption of robotic-assisted procedures and image-guided navigation systems is improving surgical outcomes, further driving market adoption. Favorable reimbursement policies and increased healthcare expenditure on pain management solutions are also contributing to market growth. Additionally, the rising prevalence of sedentary lifestyles and obesity is increasing the incidence of lower back pain, prompting more patients to seek surgical solutions. As research continues to refine treatment approaches, the sacroiliac joint fusion market is poised for sustained expansion.Report Scope
The report analyzes the Sacroiliac Joint Fusion Injections and RF Ablation market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.Segments: Indication (Degenerative Sacroilitis, Sacral Disruption, Trauma); Type (Diagnosis, Treatment); End-Use (Hospitals, Ambulatory Surgery Centers, Others)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Degenerative Sacroilitis segment, which is expected to reach US$989.3 Million by 2030 with a CAGR of a 22.0%. The Sacral Disruption segment is also set to grow at 16.7% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $135.8 Million in 2024, and China, forecasted to grow at an impressive 26.6% CAGR to reach $345.4 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Sacroiliac Joint Fusion Injections and RF Ablation Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Sacroiliac Joint Fusion Injections and RF Ablation Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Sacroiliac Joint Fusion Injections and RF Ablation Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Abbott Laboratories, Aesculap Implant Systems, LLC, Amedica Corporation, Aurora Spine Corporation, Boston Scientific Corporation and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 34 Featured):
- Abbott Laboratories
- Aesculap Implant Systems, LLC
- Amedica Corporation
- Aurora Spine Corporation
- Boston Scientific Corporation
- CornerLoc
- Globus Medical, Inc.
- Life Spine, Inc.
- Medtronic plc
- NuVasive, Inc.
- Orthofix Medical Inc.
- PainTEQ
- RTI Surgical Holdings, Inc.
- SI-BONE, Inc.
- Stratus Medical
- Surgalign Holdings, Inc.
- Tenon Medical, Inc.
- Xtant Medical Holdings, Inc.
- Zimmer Biomet Holdings, Inc.
- Zyga Technology, Inc.
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
What’s Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free July 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Aesculap Implant Systems, LLC
- Amedica Corporation
- Aurora Spine Corporation
- Boston Scientific Corporation
- CornerLoc
- Globus Medical, Inc.
- Life Spine, Inc.
- Medtronic plc
- NuVasive, Inc.
- Orthofix Medical Inc.
- PainTEQ
- RTI Surgical Holdings, Inc.
- SI-BONE, Inc.
- Stratus Medical
- Surgalign Holdings, Inc.
- Tenon Medical, Inc.
- Xtant Medical Holdings, Inc.
- Zimmer Biomet Holdings, Inc.
- Zyga Technology, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 64 |
| Published | May 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 498.4 Million |
| Forecasted Market Value ( USD | $ 1500 Million |
| Compound Annual Growth Rate | 20.1% |
| Regions Covered | Global |
